<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Endocrinol Metab</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Endocrinol. Metab</journal-id>
<journal-id journal-id-type="publisher-id">jcem</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Endocrinology and Metabolism</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-972X</issn>
<issn pub-type="epub">1945-7197</issn>
<publisher>
<publisher-name>Endocrine Society</publisher-name>
<publisher-loc>Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30085125</article-id>
<article-id pub-id-type="pmc">6194807</article-id>
<article-id pub-id-type="publisher-id">jcem_201801067</article-id>
<article-id pub-id-type="doi">10.1210/jc.2018-01067</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Research Articles</subject>
<subj-group subj-group-type="category-toc-heading">
<subject>Obesity and Adipocyte Biology</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Glucose Homeostasis and Energy Balance in Children With Pseudohypoparathyroidism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Perez</surname>
<given-names>Katia M</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Curley</surname>
<given-names>Kathleen L</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Slaughter</surname>
<given-names>James C</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shoemaker</surname>
<given-names>Ashley H</given-names>
</name>
<!--<email>ashley.h.shoemaker@vumc.org</email>-->
<xref ref-type="corresp" rid="c1"></xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>Wake Forest University School of Medicine, Winston-Salem, North Carolina</aff>
<aff id="aff2"><label>2</label>The George Washington University School of Medicine and Health Sciences, Washington, DC</aff>
<aff id="aff3"><label>3</label>Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee</aff>
<aff id="aff4"><label>4</label>Department of Pediatrics, Division of Pediatric Endocrinology, Vanderbilt University Medical Center, Nashville, Tennessee</aff>
<author-notes>
<corresp id="c1"><bold><italic>Correspondence and Reprint Requests:</italic></bold> Ashley H. Shoemaker, MD, Department of Pediatrics, Division of Pediatric Endocrinology, Vanderbilt University Medical Center, 1500 21st Avenue South Street, Suite 1514, Nashville, Tennessee 37212. E-mail: <email>ashley.h.shoemaker@vumc.org</email>.</corresp>
</author-notes>
<pub-date pub-type="collection">
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2018-08-03" pub-type="epub">
<day>03</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>11</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="collection"/>. -->
<volume>103</volume>
<issue>11</issue>
<fpage>4265</fpage>
<lpage>4274</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Endocrine Society</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<self-uri xlink:href="jc.2018-01067.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<sec id="s1">
<title>Context</title>
<p>Pseudohypoparathyroidism (PHP) is a rare genetic disorder characterized by early-onset obesity and multihormone resistance. To treat abnormal weight gain and prevent complications such as diabetes, we must understand energy balance and glucose homeostasis in PHP types 1A and 1B.</p>
</sec>
<sec id="s2">
<title>Objective</title>
<p>The aim of this study was to evaluate food intake, energy expenditure, and glucose homeostasis in children with PHP.</p>
</sec>
<sec id="s3">
<title>Design</title>
<p>Assessments included resting energy expenditure (REE), physical activity, food intake, sucrose preference, questionnaires, endocrine status, and auxological status. All patients underwent an oral glucose tolerance test (OGTT).</p>
</sec>
<sec id="s4">
<title>Setting</title>
<p>Vanderbilt University Medical Center.</p>
</sec>
<sec id="s5">
<title>Patients</title>
<p>We assessed 16 children with PHP1A, three with PHP1B, and 15 healthy controls.</p>
</sec>
<sec id="s6">
<title>Main Outcome Measures</title>
<p>Food intake during an <italic>ad lib</italic> buffet meal and glucose at five time points during OGTT.</p>
</sec>
<sec id="s7">
<title>Results</title>
<p>PHP1A and control groups were well matched. Participants with PHP1A had significantly lower REE without concomitant change in food intake or physical activity. At baseline, participants with PHP1A had significantly lower fasting glucose and insulin resistance. During OGTT, participants with PHP1A had significantly delayed peak glucose and a slower rate of glucose decline despite similar oral glucose insulin sensitivity. Participants with PHP1A had 0.46% lower HbA1c levels than controls from a clinic database after adjustment for OGTT 2-hour glucose. The PHP1B group was similar to the PHP1A group.</p>
</sec>
<sec id="s8">
<title>Conclusions</title>
<p>In contrast to other monogenic obesity syndromes, our results support reduced energy expenditure, not severe hyperphagia, as the primary cause of abnormal weight gain in PHP. Patients with PHP are at high risk for dysglycemia without reduced insulin sensitivity.</p>
</sec>
</abstract>
<abstract abstract-type="teaser">
<p>Patients with PHP1A have reduced energy expenditure without concomitant change in food intake or physical activity, resulting in early-onset obesity. They may also have increased risk of dysglycemia.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Diabetes and Digestive and Kidney Diseases</named-content>
<named-content content-type="funder-identifier">10.13039/100000062</named-content>
</funding-source>
<award-id>K23 DK101689</award-id>
<award-id>DK 059637</award-id>
<award-id>DK 020593</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Center for Advancing Translational Sciences</named-content>
<named-content content-type="funder-identifier">10.13039/100006108</named-content>
</funding-source>
<award-id>UL1TR000445</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>